{"entity":{"type":"insider","cik":"0001609805","url":"/insider/0001609805","json_url":"/insider/0001609805.json","name":"Nussbaum Ran","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":54,"n_filings":15,"first":"2015-03-31","last":"2025-10-17","span_basis":"filed_date"},"name_variants":[{"name":"Nussbaum Ran","source":"filing","n_filings":15,"first_seen":"2015-03-31","last_seen":"2025-10-17"}],"transactions":[{"id":4657796,"accession":"0000921895-25-002765","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000921895-25-002765","line_url":"/filing/0000921895-25-002765","is_derivative":false,"issuer_cik":"0001568077","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001568077","owner_cik":null,"owner_name":"Kariv Tomer; Pontifax Late Stage Fund L.P.; Pontifax (China) IV L.P.; Nussbaum Ran; Pontifax (Israel) IV, L.P.; Pontifax Late Stage GP Ltd.; Pontifax (Cayman) IV L.P.; Pontifax Management 4 G.P. (2015) Ltd.","owner_display_name":"Kariv Tomer","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock, $0.0001 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4787331.0,"shares_display":"4,787,331","price_per_share":17.75,"price_display":"17.75","price_state":"stated","total_value":84975125.25,"total_display":"84,975,125.25","total_whole":"84,975,125","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-15","filed_date":"2025-10-17","scope":"insider","n_lines":4},{"id":4238096,"accession":"0001609805-25-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001609805-25-000006","line_url":"/filing/0001609805-25-000006#line-2","is_derivative":false,"issuer_cik":"0001609805","issuer_name":"LB PHARMACEUTICALS INC","issuer_ticker":"LBRX","issuer_name_source":null,"issuer_url":"/issuer/0001609805","owner_cik":"0001609805","owner_name":"Nussbaum Ran","owner_display_name":"Nussbaum Ran","owner_url":"/insider/0001609805","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":15000000.0,"total_display":"15,000,000.00","total_whole":"15,000,000","shares_owned_after":1411681.0,"shares_owned_after_display":"1,411,681","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-09-12","filed_date":"2025-09-16","scope":"insider"},{"id":5247717,"accession":"0001104659-21-067335","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-21-067335","line_url":"/filing/0001104659-21-067335","is_derivative":false,"issuer_cik":"0001035354","issuer_name":"Eloxx Pharmaceuticals, Inc.","issuer_ticker":"ELOX","issuer_name_source":null,"issuer_url":"/issuer/0001035354","owner_cik":"0001609805","owner_name":"Nussbaum Ran","owner_display_name":"Nussbaum Ran","owner_url":"/insider/0001609805","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5925925.0,"shares_display":"5,925,925","price_per_share":1.35,"price_display":"1.35","price_state":"stated","total_value":7999998.75,"total_display":"7,999,998.75","total_whole":"7,999,999","shares_owned_after":3679797.0,"shares_owned_after_display":"3,679,797","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-13","filed_date":"2021-05-17","scope":"insider","n_lines":4},{"id":2517479,"accession":"0001209191-20-059411","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-059411","line_url":"/filing/0001209191-20-059411","is_derivative":false,"issuer_cik":"0001609805","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001609805","owner_cik":null,"owner_name":"Pontifax (China) IV L.P.; Pontifax Late Stage GP Ltd.; Pontifax (Israel) IV, L.P.; Pontifax (Cayman) IV L.P.; Pontifax Late Stage Fund L.P.; Nussbaum Ran","owner_display_name":"Pontifax (China) IV L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":2288151.0,"shares_owned_after_display":"2,288,151","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-11-19","scope":"insider","n_lines":4},{"id":3113126,"accession":"0001209191-20-024229","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001209191-20-024229","line_url":"/filing/0001209191-20-024229","is_derivative":false,"issuer_cik":"0001609805","issuer_name":"Keros Therapeutics, Inc.","issuer_ticker":"KROS","issuer_name_source":null,"issuer_url":"/issuer/0001609805","owner_cik":"0001609805","owner_name":"Nussbaum Ran","owner_display_name":"Nussbaum Ran","owner_url":"/insider/0001609805","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":437499.0,"shares_display":"437,499","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":6999984.0,"total_display":"6,999,984.00","total_whole":"6,999,984","shares_owned_after":2261517.0,"shares_owned_after_display":"2,261,517","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-04-13","filed_date":"2020-04-13","scope":"insider","n_lines":4},{"id":8236323,"accession":"0001019695-19-000026","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001019695-19-000026","line_url":"/filing/0001019695-19-000026","is_derivative":false,"issuer_cik":"0001019695","issuer_name":"ARQULE INC","issuer_ticker":"ARQL","issuer_name_source":null,"issuer_url":"/issuer/0001019695","owner_cik":"0001609805","owner_name":"Nussbaum Ran","owner_display_name":"Nussbaum Ran","owner_url":"/insider/0001609805","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":307692.0,"shares_display":"307,692","price_per_share":9.75,"price_display":"9.75","price_state":"stated","total_value":2999997.0,"total_display":"2,999,997.00","total_whole":"2,999,997","shares_owned_after":3482224.0,"shares_owned_after_display":"3,482,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-27","filed_date":"2019-07-01","scope":"insider","n_lines":4},{"id":8001379,"accession":"0001144204-19-032486","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001144204-19-032486","line_url":"/filing/0001144204-19-032486","is_derivative":false,"issuer_cik":"0001035354","issuer_name":"Eloxx Pharmaceuticals, Inc.","issuer_ticker":"ELOX","issuer_name_source":null,"issuer_url":"/issuer/0001035354","owner_cik":"0001609805","owner_name":"Nussbaum Ran","owner_display_name":"Nussbaum Ran","owner_url":"/insider/0001609805","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":1800000.0,"total_display":"1,800,000.00","total_whole":"1,800,000","shares_owned_after":1049310.0,"shares_owned_after_display":"1,049,310","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-24","filed_date":"2019-06-26","scope":"insider","n_lines":4},{"id":6493096,"accession":"0001019695-18-000024","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001019695-18-000024","line_url":"/filing/0001019695-18-000024","is_derivative":false,"issuer_cik":"0001019695","issuer_name":"ARQULE INC","issuer_ticker":"ARQL","issuer_name_source":null,"issuer_url":"/issuer/0001019695","owner_cik":"0001609805","owner_name":"Nussbaum Ran","owner_display_name":"Nussbaum Ran","owner_url":"/insider/0001609805","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":181818.0,"shares_display":"181,818","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":999999.0,"total_display":"999,999.00","total_whole":"999,999","shares_owned_after":3348676.0,"shares_owned_after_display":"3,348,676","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-07-13","filed_date":"2018-10-22","scope":"insider","n_lines":3},{"id":9216754,"accession":"0001019695-18-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001019695-18-000021","line_url":"/filing/0001019695-18-000021#line-1","is_derivative":false,"issuer_cik":"0001019695","issuer_name":"ARQULE INC","issuer_ticker":"ARQL","issuer_name_source":null,"issuer_url":"/issuer/0001019695","owner_cik":"0001609805","owner_name":"Nussbaum Ran","owner_display_name":"Nussbaum Ran","owner_url":"/insider/0001609805","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8611.0,"shares_display":"8,611","price_per_share":3.29,"price_display":"3.29","price_state":"stated","total_value":28330.19,"total_display":"28,330.19","total_whole":"28,330","shares_owned_after":8611.0,"shares_owned_after_display":"8,611","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-18","filed_date":"2018-05-22","scope":"insider"},{"id":6602166,"accession":"0001019695-18-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001019695-18-000020","line_url":"/filing/0001019695-18-000020#line-1","is_derivative":false,"issuer_cik":"0001019695","issuer_name":"ARQULE INC","issuer_ticker":"ARQL","issuer_name_source":null,"issuer_url":"/issuer/0001019695","owner_cik":"0001609805","owner_name":"Nussbaum Ran","owner_display_name":"Nussbaum Ran","owner_url":"/insider/0001609805","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8611.0,"shares_display":"8,611","price_per_share":3.29,"price_display":"3.29","price_state":"stated","total_value":28330.19,"total_display":"28,330.19","total_whole":"28,330","shares_owned_after":8611.0,"shares_owned_after_display":"8,611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-18","filed_date":"2018-05-18","scope":"insider"},{"id":6903561,"accession":"0001209191-18-027112","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-027112","line_url":"/filing/0001209191-18-027112","is_derivative":false,"issuer_cik":"0001035354","issuer_name":"Eloxx Pharmaceuticals, Inc.","issuer_ticker":"ELOX","issuer_name_source":null,"issuer_url":"/issuer/0001035354","owner_cik":"0001609805","owner_name":"Nussbaum Ran","owner_display_name":"Nussbaum Ran","owner_url":"/insider/0001609805","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":9.75,"price_display":"9.75","price_state":"stated","total_value":3412500.0,"total_display":"3,412,500.00","total_whole":"3,412,500","shares_owned_after":962504.0,"shares_owned_after_display":"962,504","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-04-30","filed_date":"2018-05-01","scope":"insider","n_lines":3},{"id":6357498,"accession":"0001209191-18-021398","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-18-021398","line_url":"/filing/0001209191-18-021398","is_derivative":false,"issuer_cik":"0001035354","issuer_name":"Eloxx Pharmaceuticals, Inc.","issuer_ticker":"ELOX","issuer_name_source":null,"issuer_url":"/issuer/0001035354","owner_cik":"0001609805","owner_name":"Nussbaum Ran","owner_display_name":"Nussbaum Ran","owner_url":"/insider/0001609805","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":48000.0,"total_display":"48,000.00","total_whole":"48,000","shares_owned_after":789878.0,"shares_owned_after_display":"789,878","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-22","filed_date":"2018-03-23","scope":"insider","n_lines":3},{"id":6357486,"accession":"0001209191-18-021398","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-021398","line_url":"/filing/0001209191-18-021398","is_derivative":false,"issuer_cik":"0001035354","issuer_name":"Eloxx Pharmaceuticals, Inc.","issuer_ticker":"ELOX","issuer_name_source":null,"issuer_url":"/issuer/0001035354","owner_cik":"0001609805","owner_name":"Nussbaum Ran","owner_display_name":"Nussbaum Ran","owner_url":"/insider/0001609805","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6600.0,"shares_display":"6,600","price_per_share":7.55,"price_display":"7.55","price_state":"stated","total_value":49830.0,"total_display":"49,830.00","total_whole":"49,830","shares_owned_after":786919.0,"shares_owned_after_display":"786,919","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-21","filed_date":"2018-03-23","scope":"insider","n_lines":3},{"id":4709138,"accession":"0001209191-17-031484","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-031484","line_url":"/filing/0001209191-17-031484","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001609805","owner_name":"Nussbaum Ran","owner_display_name":"Nussbaum Ran","owner_url":"/insider/0001609805","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9832.0,"shares_display":"9,832","price_per_share":69.10842961757527,"price_display":"69.11","price_state":"stated","total_value":679474.08,"total_display":"679,474.08","total_whole":"679,474","shares_owned_after":3520.0,"shares_owned_after_display":"3,520","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-05-09","filed_date":"2017-05-11","scope":"insider","n_lines":4},{"id":8536720,"accession":"0001209191-15-049860","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-049860","line_url":"/filing/0001209191-15-049860","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001609805","owner_name":"Nussbaum Ran","owner_display_name":"Nussbaum Ran","owner_url":"/insider/0001609805","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":224674.0,"shares_display":"224,674","price_per_share":55.35677773129067,"price_display":"55.36","price_state":"stated","total_value":12437228.68,"total_display":"12,437,228.68","total_whole":"12,437,229","shares_owned_after":24070.0,"shares_owned_after_display":"24,070","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-02","filed_date":"2015-06-03","scope":"insider","n_lines":2},{"id":8536713,"accession":"0001209191-15-049860","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-049860","line_url":"/filing/0001209191-15-049860","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001609805","owner_name":"Nussbaum Ran","owner_display_name":"Nussbaum Ran","owner_url":"/insider/0001609805","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80760.0,"shares_display":"80,760","price_per_share":55.339649083704806,"price_display":"55.34","price_state":"stated","total_value":4469230.06,"total_display":"4,469,230.06","total_whole":"4,469,230","shares_owned_after":236228.0,"shares_owned_after_display":"236,228","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-06-01","filed_date":"2015-06-03","scope":"insider","n_lines":3},{"id":8575366,"accession":"0001209191-15-030533","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-15-030533","line_url":"/filing/0001209191-15-030533#line-6","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001609805","owner_name":"Nussbaum Ran","owner_display_name":"Nussbaum Ran","owner_url":"/insider/0001609805","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66948.0,"shares_display":"66,948","price_per_share":59.9141,"price_display":"59.91","price_state":"stated","total_value":4011129.1668,"total_display":"4,011,129.17","total_whole":"4,011,129","shares_owned_after":149116.0,"shares_owned_after_display":"149,116","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-03-30","filed_date":"2015-03-31","scope":"insider"},{"id":8575362,"accession":"0001209191-15-030533","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-15-030533","line_url":"/filing/0001209191-15-030533#line-5","is_derivative":false,"issuer_cik":"0001510580","issuer_name":"Kite Pharma, Inc.","issuer_ticker":"KITE","issuer_name_source":null,"issuer_url":"/issuer/0001510580","owner_cik":"0001609805","owner_name":"Nussbaum Ran","owner_display_name":"Nussbaum Ran","owner_url":"/insider/0001609805","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25560.0,"shares_display":"25,560","price_per_share":59.9141,"price_display":"59.91","price_state":"stated","total_value":1531404.396,"total_display":"1,531,404.40","total_whole":"1,531,404","shares_owned_after":43604.0,"shares_owned_after_display":"43,604","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-03-30","filed_date":"2015-03-31","scope":"insider"}],"collapsed":true,"next_cursor":"2015-03-30|8575362","ledger_fault":false,"count":{"value":46,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":35,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":46},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001664710","name":"Keros Therapeutics, Inc.","url":"/issuer/0001664710","role":"Director, Ten percent owner","n_filings":3,"first_seen":"2020-04-13","last_seen":"2025-10-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001691082","name":"LB PHARMACEUTICALS INC","url":"/issuer/0001691082","role":"Director","n_filings":1,"first_seen":"2025-09-16","last_seen":"2025-09-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001035354","name":"Eloxx Pharmaceuticals, Inc.","url":"/issuer/0001035354","role":"Director","n_filings":4,"first_seen":"2018-03-23","last_seen":"2021-05-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001019695","name":"ARQULE INC","url":"/issuer/0001019695","role":"Director","n_filings":4,"first_seen":"2018-05-18","last_seen":"2019-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001510580","name":"Kite Pharma, Inc.","url":"/issuer/0001510580","role":"Director","n_filings":3,"first_seen":"2015-03-31","last_seen":"2017-05-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001609805","retrieved_at":"2026-08-22T11:26:52+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}